Acutarex PDR 60
Commercial- Indications
- Diabetic foot ulcers, Venous ulcers, Pressure ulcers
Company intelligence / Profile preview
Alliance Healing Technologies has developed the Acutarex™ PDR 60 Healing System—a proprietary technology that balances MMPs to optimize chronic wound healing. Their solution includes advanced bandages and a digital app for patient management. The system has received FDA clearance via the medical device pathway and claims efficacy across more than two hundred types of wounds. Clinical study data show that up to ~69% of patients achieved at least a 50% reduction in chronic wound area after treatment periods averaging around nine weeks. The company offers an industry-first warranty on outcomes backed by Lockton Texas insurance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alliance Healing Technologies.